Angiotensin-converting enzyme inhibitors prevent LDL-induced endothelial dysfunction by reduction of asymmetric dimethylarginine level

被引：19

作者：

Jiang, JL ^{[1
]}

Zhu, HQ ^{[1
]}

Chen, Z ^{[1
]}

Xu, HY ^{[1
]}

Li, YJ ^{[1
]}

机构：

[1] Cent S Univ, Dept Pharmacol, Sch Pharmaceut Sci, Changsha 410078, Peoples R China

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2005年 / 101卷 / 01期

关键词：

angiotensin-converting enzyme inhibitors; low-density lipoprotein; dimethylarginine;

D O I：

10.1016/j.ijcard.2004.01.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：153 / 155

页数：3

共 6 条

[1] Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG, NG-dimethylarginine in human essential hypertension [J].

Delles, C ;

Schneider, MP ;

John, S ;

Gekle, M ;

Schmieder, RE .

AMERICAN JOURNAL OF HYPERTENSION, 2002, 15 (07) :590-593

[2] Novel mechanism for endothelial dysfunction - Dysregulation of dimethylarginine dimethylaminohydrolase [J].

Ito, A ;

Tsao, PS ;

Adimoolam, S ;

Kimoto, M ;

Ogawa, T ;

Cooke, JP .

CIRCULATION, 1999, 99 (24) :3092-3095

[3] Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension [J].

Ito, A ;

Egashira, K ;

Narishige, T ;

Muramatsu, K ;

Takeshita, A .

JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 2001, 65 (09) :775-778

[4] Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine [J].

Jiang, DJ ;

Jiang, JL ;

Tan, GS ;

Du, YH ;

Xu, KP ;

Li, YJ .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 (06) :600-606

[5] Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level [J].

Jiang, JL ;

Li, NS ;

Li, YJ ;

Deng, HW .

BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (05) :1175-1182

[6]

Vavrínková H, 2001, PHYSIOL RES, V50, P481

← 1 →